Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Ku

Showing results (361-370 of 392) with videos related to

Pageof 40
Sort By:
Annals of Surgery|July 12, 2023
Unique Genomic Alterations and Microbial Profiles Identified in Patients With Gastric Cancer of African, European, and Asian Ancestry: A Novel Path for Precision OncologyMiseker Abate, Henry Walch, Kanika Arora, et al.
Journal of Cataract and Refractive Surgery|March 26, 2013
Comparison of macular morphology between femtosecond laser-assisted and traditional cataract surgeryJenny L Lauschke, Shahriar Amjadi, Oliver C F Lau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2022
The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal AdenocarcinomaSmita Sihag, Samuel C Nussenzweig, Henry S Walch, et al.
The British Journal of Surgery|September 3, 2021
Prognosis after neoadjuvant chemoradiation or chemotherapy for locally advanced gastro-oesophageal junctional adenocarcinomaE L Vos, R A Carr, M Hsu, et al.
The Oncologist|December 2, 2025
Characterization of the safety profile of trastuzumab deruxtecan by dose: a pooled analysis across DESTINY studiesYeon Hee Park, Javier Cortes, Shanu Modi, et al.
Annals of Surgery|August 13, 2021
Induction FOLFOX and PET-Directed Chemoradiation for Locally Advanced Esophageal AdenocarcinomaRebecca A Carr, Meier Hsu, Caitlin A Harrington, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 21, 2024
<sup>18</sup>F-BMS-986229 PET to Assess Programmed-Death Ligand 1 Status in Gastroesophageal CancerSamuel L Cytryn, Neeta Pandit-Taskar, Melissa A Lumish, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2019
Clinical and Molecular Predictors of Response to Immune Checkpoint Inhibitors in Patients with Advanced Esophagogastric CancerMegan Greally, Joanne F Chou, Walid K Chatila, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2008
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefitJianda Yuan, Sacha Gnjatic, Hao Li, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 24, 2024
Esophagectomy may have a role in stage IV esophageal adenocarcinomaMarisa Sewell, Nicolas Toumbacaris, Kay See Tan, et al.
Pageof 40

Showing results (361-370 of 392) with videos related to

Sort By:
Pageof 40
Annals of Surgery|July 12, 2023
Unique Genomic Alterations and Microbial Profiles Identified in Patients With Gastric Cancer of African, European, and Asian Ancestry: A Novel Path for Precision OncologyMiseker Abate, Henry Walch, Kanika Arora, et al.
Journal of Cataract and Refractive Surgery|March 26, 2013
Comparison of macular morphology between femtosecond laser-assisted and traditional cataract surgeryJenny L Lauschke, Shahriar Amjadi, Oliver C F Lau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2022
The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal AdenocarcinomaSmita Sihag, Samuel C Nussenzweig, Henry S Walch, et al.
The British Journal of Surgery|September 3, 2021
Prognosis after neoadjuvant chemoradiation or chemotherapy for locally advanced gastro-oesophageal junctional adenocarcinomaE L Vos, R A Carr, M Hsu, et al.
The Oncologist|December 2, 2025
Characterization of the safety profile of trastuzumab deruxtecan by dose: a pooled analysis across DESTINY studiesYeon Hee Park, Javier Cortes, Shanu Modi, et al.
Annals of Surgery|August 13, 2021
Induction FOLFOX and PET-Directed Chemoradiation for Locally Advanced Esophageal AdenocarcinomaRebecca A Carr, Meier Hsu, Caitlin A Harrington, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 21, 2024
<sup>18</sup>F-BMS-986229 PET to Assess Programmed-Death Ligand 1 Status in Gastroesophageal CancerSamuel L Cytryn, Neeta Pandit-Taskar, Melissa A Lumish, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2019
Clinical and Molecular Predictors of Response to Immune Checkpoint Inhibitors in Patients with Advanced Esophagogastric CancerMegan Greally, Joanne F Chou, Walid K Chatila, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2008
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefitJianda Yuan, Sacha Gnjatic, Hao Li, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 24, 2024
Esophagectomy may have a role in stage IV esophageal adenocarcinomaMarisa Sewell, Nicolas Toumbacaris, Kay See Tan, et al.
Pageof 40